Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Michael Harris-Love

Concepts (166)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Muscle Strength
13
2024
270
2.850
Why?
Myositis, Inclusion Body
5
2015
11
1.540
Why?
Myositis
8
2015
44
1.510
Why?
Ultrasonography
4
2024
633
1.430
Why?
Muscle, Skeletal
11
2024
1472
1.030
Why?
Heel
2
2014
9
0.910
Why?
Quadriceps Muscle
3
2024
104
0.830
Why?
Dermatomyositis
6
2022
23
0.820
Why?
Gait
5
2015
249
0.790
Why?
Lower Extremity
3
2024
335
0.780
Why?
Multiple Sclerosis
2
2024
376
0.770
Why?
Polymyositis
5
2014
15
0.720
Why?
Exercise Therapy
4
2013
350
0.720
Why?
Sarcoma, Kaposi
2
2009
68
0.530
Why?
Physical Therapists
1
2015
39
0.460
Why?
Isometric Contraction
2
2013
155
0.450
Why?
Range of Motion, Articular
2
2019
350
0.440
Why?
Ankle
1
2013
70
0.430
Why?
Skin Neoplasms
2
2009
756
0.330
Why?
Muscle Neoplasms
1
2009
8
0.330
Why?
Knee Joint
2
2009
323
0.330
Why?
Arthralgia
1
2009
46
0.320
Why?
Middle Aged
16
2024
26719
0.300
Why?
Renal Insufficiency, Chronic
2
2024
486
0.290
Why?
Friedreich Ataxia
2
2009
64
0.290
Why?
Physicians
1
2015
772
0.280
Why?
Severity of Illness Index
6
2014
2537
0.260
Why?
Male
22
2024
55555
0.240
Why?
Humans
33
2024
114624
0.230
Why?
Motor Activity
2
2009
640
0.230
Why?
Adult
17
2024
30528
0.220
Why?
Foot Diseases
1
2004
32
0.220
Why?
Muscle Weakness
4
2013
80
0.220
Why?
Exercise Tolerance
2
2009
213
0.220
Why?
Aged
10
2024
19061
0.220
Why?
Weight-Bearing
1
2004
165
0.210
Why?
Antibodies, Monoclonal, Murine-Derived
2
2014
82
0.210
Why?
Female
20
2024
59466
0.210
Why?
HIV Infections
2
2009
2469
0.210
Why?
Predictive Value of Tests
4
2014
1796
0.200
Why?
Leg
1
2004
225
0.200
Why?
Resistance Training
1
2024
113
0.200
Why?
Activities of Daily Living
2
2009
349
0.200
Why?
Cross-Sectional Studies
3
2023
4405
0.200
Why?
Physical Therapy Modalities
1
2004
264
0.180
Why?
Bulbo-Spinal Atrophy, X-Linked
2
2011
3
0.180
Why?
Immunosuppressive Agents
2
2017
646
0.170
Why?
Dance Therapy
1
2019
3
0.160
Why?
Video Games
1
2019
21
0.160
Why?
Muscular Diseases
2
2015
104
0.160
Why?
Hand Strength
1
2018
95
0.150
Why?
Infliximab
1
2017
94
0.140
Why?
Dermatologic Agents
1
2017
57
0.140
Why?
Kidney Failure, Chronic
1
2022
489
0.140
Why?
Exercise
3
2024
1644
0.130
Why?
Hypertension
1
2024
1056
0.130
Why?
Reproducibility of Results
5
2015
2762
0.120
Why?
International Cooperation
1
2005
171
0.120
Why?
Accidental Falls
2
2014
150
0.120
Why?
Aging
1
2024
1618
0.120
Why?
Quality of Life
2
2009
2353
0.110
Why?
Veterans
1
2024
1248
0.110
Why?
Terminology as Topic
1
2004
187
0.110
Why?
Biomechanical Phenomena
1
2015
668
0.100
Why?
Immunologic Factors
1
2014
220
0.100
Why?
Age Factors
1
2018
2894
0.100
Why?
Disease Management
1
2005
560
0.100
Why?
Azasteroids
1
2011
4
0.090
Why?
Clinical Trials as Topic
1
2005
931
0.090
Why?
Antirheumatic Agents
1
2013
255
0.090
Why?
Patellofemoral Pain Syndrome
1
2009
6
0.080
Why?
Ubiquinone
1
2009
21
0.080
Why?
Sensitivity and Specificity
1
2014
1691
0.080
Why?
Antibodies, Neoplasm
1
2009
30
0.080
Why?
Analysis of Variance
2
2008
1226
0.080
Why?
CD4 Lymphocyte Count
1
2009
257
0.080
Why?
L-Lactate Dehydrogenase
1
2008
107
0.080
Why?
Child
9
2022
18404
0.080
Why?
Muscle Stretching Exercises
1
2008
17
0.080
Why?
Treatment Outcome
8
2017
9084
0.080
Why?
Practice Guidelines as Topic
1
2005
1394
0.070
Why?
Viral Load
1
2009
405
0.070
Why?
Radiography
1
2009
812
0.070
Why?
Osteoarthritis, Knee
1
2009
213
0.070
Why?
Linear Models
1
2008
768
0.070
Why?
Immunoglobulins, Intravenous
1
2007
122
0.060
Why?
Double-Blind Method
3
2017
1660
0.060
Why?
Diagnosis, Differential
1
2009
1342
0.060
Why?
Magnetic Resonance Imaging
2
2022
3039
0.060
Why?
Walkers
1
2004
2
0.060
Why?
Lymphedema
1
2004
20
0.060
Why?
Sickness Impact Profile
1
2003
50
0.060
Why?
Single-Blind Method
1
2024
258
0.050
Why?
Task Performance and Analysis
1
2004
159
0.050
Why?
Antibodies, Monoclonal
1
2009
1262
0.050
Why?
Muscle Fatigue
1
2003
94
0.050
Why?
Rituximab
2
2014
150
0.050
Why?
Regional Blood Flow
1
2024
424
0.050
Why?
Physical Fitness
1
2003
179
0.050
Why?
Adolescent
6
2013
17831
0.050
Why?
Disability Evaluation
1
2003
271
0.050
Why?
Follow-Up Studies
3
2011
4411
0.050
Why?
Risk Factors
1
2014
8628
0.050
Why?
Child, Preschool
3
2009
9108
0.050
Why?
Fatigue
1
2022
294
0.040
Why?
Cicatrix
1
2009
50
0.040
Why?
Muscular Atrophy
1
2009
78
0.040
Why?
Disease Progression
2
2011
2380
0.040
Why?
Randomized Controlled Trials as Topic
1
2024
1214
0.040
Why?
Biomarkers
1
2008
3408
0.040
Why?
Pilot Projects
2
2017
1372
0.040
Why?
Retrospective Studies
2
2009
12542
0.040
Why?
Independent Living
1
2019
84
0.040
Why?
Calcinosis
1
2009
242
0.040
Why?
Prednisone
1
2017
229
0.030
Why?
Cross-Over Studies
1
2017
440
0.030
Why?
Prognosis
1
2003
3328
0.030
Why?
Drug Administration Schedule
1
2017
718
0.030
Why?
Drug Therapy, Combination
1
2017
951
0.030
Why?
Risk Assessment
1
2003
2967
0.030
Why?
Aged, 80 and over
2
2019
6344
0.030
Why?
Incidence
1
2009
2311
0.030
Why?
Inflammation
1
2024
2478
0.030
Why?
Consensus
1
2005
537
0.030
Why?
Muscle Contraction
2
2008
389
0.030
Why?
Placebos
1
2013
197
0.030
Why?
Observer Variation
2
2006
295
0.030
Why?
Walking
2
2009
422
0.020
Why?
Obesity
1
2024
2507
0.020
Why?
Dutasteride
1
2011
4
0.020
Why?
Pain Measurement
1
2013
444
0.020
Why?
Electrodiagnosis
1
2009
15
0.020
Why?
Gait Apraxia
1
2009
1
0.020
Why?
Erectile Dysfunction
1
2009
38
0.020
Why?
Neural Conduction
1
2009
78
0.020
Why?
Alemtuzumab
1
2009
12
0.020
Why?
Peripheral Nerves
1
2009
64
0.020
Why?
Lymphocyte Count
1
2009
133
0.020
Why?
Lymphocyte Depletion
1
2009
116
0.020
Why?
Glucocorticoids
1
2013
532
0.020
Why?
Proprioception
1
2008
19
0.020
Why?
Androgens
1
2009
167
0.020
Why?
Age of Onset
1
2009
445
0.020
Why?
Electromyography
1
2009
326
0.020
Why?
Surveys and Questionnaires
2
2009
4620
0.020
Why?
Action Potentials
1
2009
406
0.020
Why?
Injections, Intravenous
1
2007
198
0.020
Why?
Autoantibodies
1
2014
1345
0.020
Why?
Testosterone
1
2009
343
0.020
Why?
Inflammation Mediators
1
2009
477
0.020
Why?
Infusions, Intravenous
1
2007
371
0.020
Why?
Antioxidants
1
2009
530
0.020
Why?
Fractures, Bone
1
2011
367
0.020
Why?
Biopsy
1
2009
1036
0.020
Why?
Recovery of Function
1
2009
574
0.020
Why?
Physical Therapy Specialty
1
2006
34
0.020
Why?
Statistics, Nonparametric
1
2006
385
0.020
Why?
Antibodies, Monoclonal, Humanized
1
2009
663
0.010
Why?
CD8-Positive T-Lymphocytes
1
2009
687
0.010
Why?
CD4-Positive T-Lymphocytes
1
2009
959
0.010
Why?
Dose-Response Relationship, Drug
1
2007
1842
0.010
Why?
RNA, Messenger
1
2009
2552
0.010
Why?
Physical Examination
1
2003
222
0.010
Why?
Gene Expression Regulation
1
2009
2319
0.010
Why?
Time Factors
1
2009
6112
0.010
Why?
Exercise Test
1
2000
544
0.010
Why?
Harris-Love's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)